Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.
肺动脉高压中内皮细胞的回补重编程。
基本信息
- 批准号:9154826
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAntioxidantsApoptosisApoptoticAttenuatedBindingBlood VesselsCell ProliferationCell SurvivalCell physiologyCellular StressCessation of lifeCharacteristicsChargeCitric Acid CycleDataDiseaseEndothelial CellsEnsureEquilibriumEventFRAP1 geneHeart failureHypoxiaInhibition of ApoptosisKnockout MiceLesionLungMalignant NeoplasmsMediatingMitochondriaModelingModificationNitratesOxaloacetatesOxidative PhosphorylationOxidative StressPDPK1 genePTEN genePathologicPathway interactionsPatientsPeptidesPeroxonitritePhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPlayProductionProteinsPublishingPulmonary HypertensionPulmonary artery structurePyruvatePyruvate CarboxylaseRattusReactionResistanceRoleSU 5416SerineSignal TransductionStress Response SignalingStructureStructure of parenchyma of lungSuperoxidesTestingTherapeuticTyrosineVascular remodelingWorkbiological adaptation to stresscell growthendothelial dysfunctionmitochondrial dysfunctionnitrationnovelpressurepulmonary arterial hypertension
项目摘要
PROJECT SUMMARY
Pulmonary arterial hypertension (PH) is a fatal disease with uncontrolled pulmonary vascular cell
proliferation. Excessive endothelial cell (EC) growth leads to the formation of plexiform lesions, which are
a characteristic cancer-like change within pulmonary arteries of patients with PH. The increased
oxidative stress in lungs of patients with PH leads to the reaction of superoxide with NO. This results in
the formation of highly reactive peroxynitrite (ONOO-) which, in turn, can produce nitro-tyrosine
modifications in proteins. Lung tissues from patients with PH have an increased level of protein nitration.
Our recently published work indicates that the nitration of tyrosine 350 residue in Akt leads to the
sustained activation of Akt signaling. The activation of Akt is a well described cell survival and stress
response but Akt activation is tightly regulated by the regulatory kinases/phosphatases (PTEN, PI3K,
PDK1 and mTOR) that control Akt activity and ensuring that it is only temporarily active. Pathological
activation of the Akt pathway has been implicated in various cancers. We hypothesize that in PH,
nitration of Akt increases translocation of eNOS to mitochondria, which downregulates oxidative
phosphorylation and activates Pyruvate Carboxylase (PC), which upregulates anaplerosis. This
activation of anaplerosis then leads to pathological hyper-proliferation of endothelial cells (EC) and
plexiform lesion formation in PH. Further, we propose to target pathological Akt signaling using an Akt-
binding peptide conjugated with an antioxidant (shielding peptide) that only affects nitration mediated Akt
activation. We will test these hypotheses in the following Aims: AIM 1: To elucidate the role of nitration
(Y350) mediated Akt activation in activation of anaplerosis in EC. AIM 2: To determine whether inhibition
of Akt nitration disrupts formation of the apoptosis resistant and proliferative EC phenotype. AIM 3: To
examine the effect of Akt shielding peptide on EC hyper-proliferation in the SU5416/hypoxia PH models.
项目总结
摘要肺动脉高压是一种肺血管细胞失控的致命性疾病。
扩散。内皮细胞(EC)过度生长会导致丛状病变的形成,这些病变
肺高压患者肺动脉内典型的癌样改变。增加的
肺组织中的氧化应激导致超氧化物与一氧化氮的反应。这将导致
生成高活性的过氧亚硝酸根(ONOO-),进而生成硝基酪氨酸
蛋白质的修饰。PH患者的肺组织蛋白质硝化水平升高。
我们最近发表的工作表明,Akt中350个酪氨酸残基的硝化导致了
Akt信号的持续激活。Akt的激活是一种被广泛描述的细胞生存和应激
但Akt的激活受到调节性蛋白激酶/磷酸酶(PTEN,PI3K,
PDK1和mTOR)来控制Akt的活动,并确保其仅暂时处于活动状态。病理性的
Akt通路的激活与多种癌症有关。我们假设在PH中,
Akt的硝化作用增加eNOS向线粒体的移位,从而下调氧化
磷酸化和激活丙酮酸羧基酶(PC),从而上调抗凝作用。这
激活失活导致内皮细胞病理性过度增殖,
PH时形成丛状病变。此外,我们建议使用Akt-1来靶向病理性Akt信号。
与抗氧化剂(屏蔽肽)结合的仅影响硝化介导Akt的结合肽
激活。我们将在以下目标检验这些假说:目标1:阐明硝化作用的作用
(Y350)介导Akt在EC中激活失活。目标2:确定抑制是否
Akt硝化作用破坏了抗凋亡和增殖的EC表型的形成。目标3:实现
在SU5416/缺氧性PH模型中检测Akt屏蔽肽对EC过度增殖的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruslan Rafikov其他文献
Ruslan Rafikov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruslan Rafikov', 18)}}的其他基金
Hemolysis and free heme signaling in pulmonary hypertension
肺动脉高压中的溶血和游离血红素信号传导
- 批准号:
10402254 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Hemolysis and free heme signaling in pulmonary hypertension
肺动脉高压中的溶血和游离血红素信号传导
- 批准号:
10152669 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Hemolysis and free heme signaling in pulmonary hypertension
肺动脉高压中的溶血和游离血红素信号传导
- 批准号:
10653822 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension
肺动脉高压中内皮细胞的回补重编程
- 批准号:
10634626 - 财政年份:2016
- 资助金额:
$ 38.38万 - 项目类别:
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension
肺动脉高压中内皮细胞的回补重编程
- 批准号:
10441800 - 财政年份:2016
- 资助金额:
$ 38.38万 - 项目类别:
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.
肺动脉高压中内皮细胞的回补重编程。
- 批准号:
9323563 - 财政年份:2016
- 资助金额:
$ 38.38万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Continuing Grant